ABCG2 and breast carcinoma: Human ABCG2 was discovered in an adriamycin/doxorubicin‐selected breast cancer cell line, MCF‐7/AdVp3000 (MCF‐7/AdrVp), and originally named Breast Cancer Resistance Protein more than 22 years ago [43, 44].